Waterfront Wealth’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,840
Closed -$6.82K 265
2024
Q2
$6.82K Buy
2,840
+250
+10% +$886 ﹤0.01% 245
2024
Q1
$9.12K Sell
2,590
-2,528
-49% -$12.7K ﹤0.01% 243
2023
Q4
$21.4K Sell
5,118
-1,062
-17% -$8.01K 0.01% 248
2023
Q3
$57.8K Sell
6,180
-1,434
-19% -$26.3K 0.02% 244
2023
Q2
$152K Buy
7,614
+445
+6% +$13.8K 0.05% 246
2023
Q1
$165K Buy
7,169
+125
+2% +$3.38K 0.05% 238
2022
Q4
$210K Sell
7,044
-1,969
-22% -$38K 0.07% 233
2022
Q3
$156K Buy
9,013
+188
+2% +$4.85K 0.06% 234
2022
Q2
$175K Buy
8,825
+600
+7% +$13.3K 0.07% 228
2022
Q1
$270K Buy
8,225
+1,475
+22% +$54.8K 0.1% 202
2021
Q4
$302K Buy
+6,750
New +$405K 0.12% 168

Other funds holding ASLN